CRISAL Study:Cancer Risk In Secreting Adrenal Lesions — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

CRISAL Study:Cancer Risk In Secreting Adrenal Lesions — Stella

Recruiting

Back to Adrenal Tumor trials

Trial locations(1 site)

Italy

General and Mininvasive Surgery Department, Pederzoli Hospital,, Peschiera del Garda, Verona, Italy.

Key details

Sponsor

University of Roma La Sapienza

Enrollment target

~300 participants

Started

August 2024

Primary completion

September 2024

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated August 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov